Citadel Advisors - RENALYTIX PLC ownership

RENALYTIX PLC's ticker is RNLX and the CUSIP is 75973T101. A total of 37 filers reported holding RENALYTIX PLC in Q1 2022. The put-call ratio across all filers is 1.88 and the average weighting 0.2%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of RENALYTIX PLC
ValueSharesWeighting
Q3 2023$18,560
-64.9%
11,600
-35.9%
0.00%
Q2 2023$52,852
-20.6%
18,100
-34.2%
0.00%
Q1 2023$66,596
+182.6%
27,519
+118.4%
0.00%
Q4 2022$23,562
-78.0%
12,600
-85.0%
0.00%
Q3 2022$107,000
-56.0%
83,869
-15.5%
0.00%
Q2 2022$243,000
-71.8%
99,245
-20.3%
0.00%
Q1 2022$861,000
-67.6%
124,473
-25.5%
0.00%
Q4 2021$2,657,000
+175.3%
167,095
+247.0%
0.00%
Q3 2021$965,000
-33.6%
48,150
+2.2%
0.00%
Q2 2021$1,454,000
+238.9%
47,109
+182.1%
0.00%
Q1 2021$429,000
+146.6%
16,700
+53.1%
0.00%
Q4 2020$174,00010,9050.00%
Other shareholders
RENALYTIX PLC shareholders Q1 2022
NameSharesValueWeighting ↓
Parian Global Management LP 459,461$3,179,0006.55%
Philosophy Capital Management LLC 725,000$5,017,0000.42%
GILDER GAGNON HOWE & CO LLC 2,822,709$19,533,0000.18%
Slate Path Capital LP 175,214$1,212,0000.06%
Granahan Investment Management 330,279$2,286,0000.06%
PINNACLE ASSOCIATES LTD 304,844$2,110,0000.04%
Harbor Advisors LLC 24,084$167,0000.03%
GOFEN & GLOSSBERG LLC /IL/ 183,224$1,268,0000.03%
Pentwater Capital Management LP 225,000$1,557,0000.02%
Summit Trail Advisors, LLC 18,497$128,0000.01%
View complete list of RENALYTIX PLC shareholders